Market . 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. Australia's largest stock trading and investment forum Australia's #1 stock forumInvex Successfully Concludes Protocol Assistance with EMA, page-2. . . A new thread to put trading comments / reasoning / opinions in. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. Met primary endpoints for phase 2 trials. 1956773. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentHREC and TGA Approval to Commence Phase 3 in AustraliaHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Can't see how this doesn't push up soon, page-508. I don't mind a capital return but you have to think that a reverse take over of some sort can happen here and that IXC would have lots of choices. ASX - Day Trading. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. 79 -0. 30 Haven’t supported share price since then on market . ASX - By Stock. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. Also took placement stock @$1. So it seems that as of 18 July the trials are still recruiting! An update was submitted to this site 3 days. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. . When can we expect some update or. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. (IXC) - see HotCopper and other bloggers' predictions - TipRanks. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Latest Posts ForumsThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. is there any news release, or SP increasing due to only the market showing interest, page-2. Charts. Join the HotCopper ASX share market forum today for free. a shell trading below cash backing, ripe. ASX - By Stock. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. , page-4. HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. , page-4. Contrast that to data from Wales in 2017 which suggests that. Notification regarding unquoted securities - IXC Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Forums. Created with Sketch. , page-5. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. IXC (ASX) Ann: Trading Halt - HotCopper. Reply. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. wonder if the GLP-1 agonist referred to in this media release. 26 area could be wrong and it could go for example to $3. Notification of cessation of securities - IXC. 05. 30 is a good sign as well. Just a matter of time really. Created with Sketch. My. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. ASX - General. Latest Posts. A handy 10 bags from here with seemingly little risk. , page-2. ASX - Day Trading. Forums. 0. , page-35. All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. , page-2. Both approaches can work, but it is not wise to confuse the two. IXC below Example of that is NEU Investor Presentation, page-3. ASX - Day Trading. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Charts. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. Share "Online registration will open 30 minutes before the Meeting. . , page-4. International Markets. **Close price adjusted for splits and dividend and/or capital gain distributions. ASX - By Stock. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. Charts. Latest Posts. IXC (ASX) Ann: Trading Halt - HotCopper. ASX - Day TradingHi all, I would like to preface the below summary written prior to the research links as being a heavily simplified summary of the company and the. Strong buy side, sell side still very thin. Some people like to gamble on stocks, others invest. Market . 40 in May 2020 and has only fallen over the subsequent 36 months. All IMO IXC Price at posting: 37. Forums. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Plans & Pricing. . June 29 (Reuters) - Invex Therapeutics Ltd (IXC) : INVEX RECEIVES UK APPROVAL TO COMMENCE PHASE III TRIAL CLINICAL TRIAL FOR PRESENDIN DRUG FOR. 91%) As of 03:35PM EST. 6% $DLM 50. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Created with Sketch. My understanding is that NEU went from around $1. Forums. 3¢. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Latest Posts. 1950. . Grabbed my first ever parcel in IXC yesterdy at 80c. Hi All, I have decided to make an IXC broker data thread, as my PAR broker data thread was very well received. Join the HotCopper ASX share market forum today for free. Proposed Capital Return to Shareholders of $14. Also took placement stock @$1. Here come the vultures. ASX - Day Trading. Join the HotCopper ASX share market forum today for free. Market . 59). Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. Forums. boolish Jellyroll hey. Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3. . LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. . Yet since market announcement of Phase 2 completion, this. British Columbia, Selkirk Mountains. Lucky for you all IXC still sits at only 60 cents. ASX - Short Term Trading. ASX - By Stock. Forex. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. AX stock on Yahoo Finance. ASX - Short Term Trading. Appreciate your input Dr T. 6% $DLM 50. ASX - By Stock. Created with Sketch. 0. ASX - Day Trading. Invex Files Pre-IND/Type B Meeting Request with US FDA IXC is a long term play mate, not a daytraders plaything as too illiquid. IXC below Example of that is NEUInvestor Presentation, page-3. Last research or update on this I listened to was by FiftyOneCapital. Created with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumUK R&D Tax Rebate. Created with Sketch. 8M ! Add to my watchlist. Invex to Present at Upcoming Tech Biotech Broker BriefingCreated with Sketch. Join the HotCopper ASX share market forum today for free. Im not expecting anything out of the ordinary apart from the fact thats its overdone and too undervalued at the stage its at. The Chart: An Opportunity at these Levels?Timeline Annotations of the IXC Chart Story Thus Far- IXC IPO'd in mid 2019 with Phase II data due Mid 2020,. Market . Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. How many friends and family got out after the last announcementshould have been released at the same time, page-34. . Created with Sketch. , page-188. ASX - By Stock. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-6. Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. ASX - Day TradingIf anyone told me a year ago, "there is a chance IXC cant progress the trial and the management all get sacked" I would agree that there was a chance, but nullified to a 1-2% black swan and worth the upside return profile. . ASX - General. 26 area could be wrong and it could go for example to $3. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - Day TradingCreated with Sketch. $100-200k might be the minimum for the market to take notice. Below is the broker data for IXC November to. Andrew Forrest , or his entities have been involved with IXC since inception. 0¢ Sentiment: Buy Disclosure: Held Bumping up this thread as $3. ASX - General. 147,415. Last edited by ejjwj: 28/06/23. It seems a massive hole within the industry of treatment *cough cough* IXC Also surprised by the amount of activity and people who have the disease. Created with Sketch. ASX - By Stock. Created with Sketch. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Latest Posts. Timeline Annotations of the IXC Chart Story Thus Far - IXC IPO'd in mid 2019 with Phase II data due Mid 2020, stock performs very well on IPO with tight T20 - The stock rose in anticipation for the Mid 2020 Phase II data read out in early 2020 - Before crashing alongside the Covid 19 Market Crash Hysteria in March 2020 AND all volume the last 18 months has led to a higher T20 ownership) meanwhile we have a mere 3 posts regarding an IXC job listing for a CMO that's description can be interpreted as hinting at a second indication. 0¢ Sentiment: Buy Disclosure: HeldHotCopper has news, discussion, prices and market data on GENESIS MINERALS LIMITED. Forums. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - By Stock. ASX - By Stock. Invex Therapeutics Ltd. About 90 percent of the U. But since the cash holding is double the market cap, there most likely more upside than down side. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. . sentiment based on opinions from HotCopper and others. ASX - Short Term Trading. It was well aware of the claims made, released such information in the prospectus (and still had a hugely successful IPO), and would have done their due diligence before entering into any agreements with the University. is 19. Learn more. Chairman's Address to Shareholders and PresentationHi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Very impressive. Date of AGM and Closing Date for Director NominationsCD is on the money once again, page-195. Investor PresentationI would be worried about holding IXC if they had no more cash. . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-8. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. 333334. ASX - By Stock. . 54am 24/11/2023 ? HotCopper has news, discussion, prices and market data on INCA MINERALS LIMITED. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. Probably been disappointed like all of usCreated with Sketch. The Phase III raise encompassed the costs for a go-it-alone reformulation strategy, with Bell Potter suggesting in a Q&A with IXC that they saved $5-6M in going with Peptron for their reformulation supply/manufacturing, alongside 12 months in time. Learn how it impacts everything we do. Join the HotCopper ASX share market. Share Appreciate the commentary and post. ASX - By Stock. 79 -0. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. ASX - Day TradingA new thread to put trading comments / reasoning / opinions in. Trading HaltDCF Valuation: IXC Intrinsic Value of $6. Forums. 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. 2 Upvote. I knew zero about the fundamentals of IXC. ASX - By Stock. In the LinkedIn About section for IXC, they list IIH, Acute Stroke and Traumatic Brain Injury. 50%. A rolling snowball gathers snow as it falls down the hill . Below is the broker data for IXC November to. Currency in USD 38. . Invex Granted Type C Meeting with FDAAppendix 4E and Annual Report to shareholders. GW Ixc once again showing why you are the best mgmt team on the ASX . All the latest Invex Therapeutics Ltd (ASX:IXC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. 0. ASX - General. , page-6. This was roughly 50/50 between lost wages and direct medical costs. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. Latest Posts. Although, IXC is trading about 3-4x lower than what I expect it to be. 1. 30 to $15 in the space of 1 and half years Bios move fast when value is recognised. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. Advertise. All IMO IXC Price at posting: 37. Quarterly Activities/Appendix 4C Cash Flow Report. Created with Sketch. IXC Price at posting: 45. Appendix 4E and Annual Report, page-3. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. Charts. A promising development for IXC, a company with a current Phase III trial that is expected to finish dosing in 12 months time, We hear from a patient from the Phase II trial completed 2 years ago, with our current Phase III trial ongoing as we speak:Simon Joyner - 14th largest holder in IXC Just a background of this board of advice. no point selling now. ASX - By Stock. IXC Valuation Report MST. Ceasing to be a substantial holder. 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. HotCopper has news, discussion, prices and market data on IONIC RARE EARTHS LIMITED. View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. . ASX - By Stock. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. 00 over the course of 2 years, and then doubled to $14 overnight on FDA approval. Market . . They have acted appropriately. I think having this out we can discuss on the way. ASX - Short Term Trading. ASX - Day TradingNotice of Webinar & Investor PresentationCreated with Sketch. ASX - Day TradingWith debt too expensive and lots of very discounted capital raisings especially in the microcap part of the market, I'd like to think that IXC can take advantage of the fact that they have cash. ASX - By Stock. 50%. , page-196. Created with Sketch. . . Discover historical prices for IXC. . Created with Sketch. Latest Posts. Last updated 10. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. Market . Advertise on HotCopper. ASX - General. I'm topping up. Invex Therapeutics Ltd. Latest Posts. Created with Sketch. ASX - By Stock. ASX - Day TradingI sold around half my shares yesterday at 25c. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. Last updated 15. 00% 21. . Share Well this is unexpected, for the first time ever for Invex, a director has purchased shares on-market. . Notice of Annual General Meeting/Proxy Form, page-2. , page-4. ASX - General. STN Saturn Metals reports high-grade gold intersections and visible gold at Apollo Hill, WAInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. IXC Price at posting. IXC Valuation Report MST. Too many factors to make an educated appraisal of buyout pre-Phase 2 or post Phase 2. . Created with Sketch. , page-17. Click for more information. Forums. IAMIncome Asset Management to boost bond sales through partnership with Netwealth. 0. 63%. Initial FDA and EMA Advice on Presendin Development, page-3. Sentiment for Invex Therapeutics Ltd. Get the edge as an investor: Subscribe to our daily newsletter for EXCLUSIVE insights into HotCopper!. With regard to costs, I'm encouraged by this statement in the release: Overall, the changes are expected to be cash neutral with respect to the original IIH EVOLVE trial costing, with recruitment anticipated to materially accelerate due to an expected significant reduction in pre-screen and screen failures. ASX - General. More. Target our investor community with our suite of Hotcopper Advertising opportunities. . Forums. Charts. Trading HaltCreated with Sketch. Created with Sketch. Charts. . Currency in USD 38. See page-34. 0% $ODM 35. , page-5. ASX - By Stock. Share. ASX - Day Trading. The fact it recovered and closed about the 1. ASX - By Stock. . Market . ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Information. Appendix 4C - quarterly There are thousands of people out there with IXC shares, you simply can not predict when one is going to sell and how much they are going to sell. Advertise on HotCopper. Transparency is our policy. Of course, IXC’s BoD need to win back credibility for the market to more fairly value IXC’s TBI ODD… Having gone through the roller-coaster over the past one week, with my emotions now settled – I will be (slowly) buying-up in. ASX - Day TradingAnother day…another approval. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. ASX - Day Trading. . Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. Ionic Rare Earths Limited is an Australia-based company that is focused on investment in. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. Market . , page-2. 0¢ Sentiment: Buy Disclosure: Held. Latest Posts. Created with Sketch. Charts. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Lots of possible reasons for this - but regardless, it points to Tom knowing that there is upside to this current SP. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. Market Wrap - Top 3 Gainers #ASXGainers: $IXC 54. IXC Price at posting: 38. Although, IXC is trading about 3-4x lower than what I expect it to be for current stage ($100M-$125M MC aka $75-100M EV) Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. I think having this out we can discuss on the way.